A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over ...

With the ink barely dry on an agreement to buy Kelonia, Eli Lilly has signed a deal to take ownership of Ajax Therapeutics ...

Xcovery Holdings, Inc. (Xcovery), an evidence-based, innovation-driven pharmaceutical company, today announced an agreement ...

Lilly is emphasising that Foundayo can be taken any time of day, without food or water restrictions, while Wegovy has to be ...

The $14-per-share deal for Organon – which was formed in 2021 as a spinout from MSD – will catapult India's Sun Pharma into ...

The Parkinson’s disease Translational Research Collaboration (PD-TRC), funded by the National Institute for Health and Care ...

Intellia Therapeutics has reported the first-ever phase 3 results with an in vivo gene-editing therapy, hereditary angioedema ...

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater. With nearly ...

Inizio Ignite reshuffles leadership as advisory model evolves. Inizio Ignite, a fully integrated advisory partner, announced ...

Moreover, it requires quick strategic thinking and often agile investment attitudes." The transformation of pharmaceutical ...

Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...

Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus ...